Loading page data

Please wait a moment

sales@persistencemarketresearch.com

Second Floor, 150 Fleet Street,
London, EC4A 2DQ.

+44 203-837-5656

108 W 39th Street, Ste 1006,
PMB2219, New York, NY 10018

+1 646-878-6329

IT Unit No. 504, 5th Floor, Icon
Tower, Baner, Pune - 411045.

+91 906 779 3500

Quick Links

Careers Terms & Conditions Return Policy Market Research Report

Customer FAQ’s Privacy Policy Sitemap

Our Partners

Secure Payments Through

Connect With Us -

Medical Devices
Automated-ESR Analyzer Market

Automated-ESR Analyzer Market Size, Share, Growth, and Regional Forecast, 2025 to 2032

Automated-ESR Analyzer Market by Product (Instruments, Consumables), Modality (Portable, Bench Top), by Analysis Time, End-user, and Regional Analysis from 2025 to 2032

ID: PMRREP22684

October 2025

197 Pages

Author : Abhijeet Surwase

Healthcare

Key Industry Highlights:

Automated ESR analyzers provide higher accuracy and standardization compared to manual methods.
Leading Product: Instruments hold around 68% market share. This dominance is due to the rising adoption of automated ESR analyzers in hospitals, diagnostic centers, and research labs, driven by the need for accuracy, faster turnaround time, and reduced manual intervention.
Leading Region: North America holds a significant share due to its advanced healthcare infrastructure.
Fast-growing Region: Asia Pacific is the fastest-growing region, driven by rising patient volumes and healthcare investments.

Key Insights	Details
Automated-ESR Analyzer Market Size (2025E)	US$407.8 Mn
Market Value Forecast (2032F)	US$575.4 Mn
Projected Growth (CAGR 2025 to 2032)	5.0%
Historical Market Growth (CAGR 2019 to 2024)	3.8%

global-automated-esr-analyzer-market-2025-2032

Get Your CustomizationGet Your Customization

Market Dynamics

Driver - Rising Burden of Inflammatory & Autoimmune Diseases

The rising prevalence of inflammatory and autoimmune diseases is a significant driver for the Automated-ESR Analyzer Market. Diseases such as rheumatoid arthritis, lupus, multiple sclerosis, and chronic infections are increasing globally due to aging populations, environmental factors, and lifestyle changes.

Since the erythrocyte sedimentation rate (ESR) is a simple, cost-effective, and widely accepted screening marker for detecting inflammation, routine monitoring of patients has become essential. Hospitals, diagnostic labs, and clinics are increasingly relying on automated ESR analyzers to manage higher test volumes efficiently, reduce human error, and ensure rapid results.

Consequently, the growing patient pool with inflammatory and autoimmune disorders directly boosts demand for automated ESR testing, making it a critical segment in clinical diagnostics and laboratory automation.

Restraints - Risk of Infections, and Presence of Erroneous Negative Results

Before being used in ordinary practice, automated erythrocyte sedimentation rate (ESR) analyzers must undergo comprehensive validation to demonstrate that they are comparable to the standard Westergren method. This is time-consuming and requires comparable evaluations for validity.

Additionally, there is a very significant danger of blood-borne infection for medical professionals who come into contact with blood samples. Due to unfavorable outcomes, many are turning to alternatives such as C-reactive protein, which offers a better signal of inflammation than ESR.

Early on in an inflammatory process, erroneous negative results are caused by the ESR's sluggish response to the acute phase reaction. Adverse medication responses are responsible for around 100,000 deaths annually in the United States.

Automated ESR analyzers are less appealing due to the unfavorable and detrimental effects of ESR caused by the use of certain medicines during therapy, such as oral contraceptives, vitamin A, aspirin, and cortisone, and this is anticipated to impede market expansion.

Opportunity - Opportunities in Emerging Economies and Introduction of Novel Products

Emerging economies in the Asia Pacific region, including those in India, China, Thailand, Indonesia, and the Philippines, have a considerable market potential. A sizable patient base and an increase in the prevalence of infectious diseases present profitable growth prospects for businesses looking to record high revenues in the automated ESR analyzer market.

Therefore, increased investments by manufacturers and new players for the introduction of technologically advanced medical equipment is dramatically expanding their global footprint. For instance, the 2020 release of the Aerospray Cytology Slide Stainer Cytocentrifuge by ELITechGroup's Staining Technology, a device that accomplishes two tasks-sample preparation by cytocentrifugation and sample staining-has increased market potential.

There are many untreated patients in emerging economies. These regions provide manufacturers a sizable window of opportunity. According to estimates, sustainability will be aided by economic growth in these developing nations and patients' rising disposable income.

Additionally, it is predicted that an increase in the amount of money that various governments spend on healthcare will encourage diagnostic laboratories to use automated ESR analyzers. It is anticipated that this will increase demand for automated ESR analyzers.

Moreover, it is projected that favourable reimbursement policies, the introduction of automated ESR analysers, and growing healthcare infrastructure in emerging nations will catalyse market demand throughout the projection period.

Category-wise Analysis

By Product, Greater Efficacy and Small Sample Requirement

Instruments held around 68% of the total market in 2025. When an instrument is fully automated from the moment a sample tube is inserted, it can be used walk-away. This is the case with fully automated ESR analyzers.

These instruments span a wide range of channels depending on the capacity needed, enabling use across numerous end-use scenarios. Modern fully automated analyzers require small sample quantities, making them ideal for testing pediatric samples.

Moreover, with semi-automated analyzers, sampling is carried out manually for equipment that use an external needle and uncapped tubes. These instruments have a few benefits, such as a reduced size that enables use in confined locations and fewer moving components that reduce the need for maintenance and/or repairs.

By Modality, Short Analysis Times, and Portability

The portable automated ESR analyzer held around 72% of the total market in 2025. Portable ESR analyzers are portable devices that use the infrared sensor measurement concept and the Westergren analysis method. They can process up to 80 samples per hour while offering a measuring range of 1 to 140 mm/h.

The majority of devices feature a maximum simultaneous sample loading capacity of 40 and two measuring durations of 30 or 60 minutes. Reduced analysis time, as well as minimal special requirements, allow this segment to hold a dominant share within the global market.

global-automated-esr-analyzer-market-by-end-user-2025-2032

Request Free sampleRequest Free sample

Region-wise Insights

North America Automated-ESR Analyzer Trends

The U.S. is set to account for around a 35% share in the global market in 2025. The adoption of modern technologies and the consolidation of medical facilities in this region are the primary drivers of market growth.

Several regulatory agencies and governments, particularly in developed economies, are implementing multiple cost-cutting strategies to lower their healthcare burden. Technological advances are clearing the way for the advancement of automated ESR analyzers beyond manual ESR analyzers, propelling the global market.

The increasing availability of automated ESR analyzers with advanced and novel technologies has boosted laboratory workflow while also improving turnaround time, which is another key reason driving global usage of automated ESR analyzers in the country.

Asia Pacific Automated-ESR Analyzer Market Trends

The Asia Pacific Automated-ESR Analyzer Market is witnessing significant growth as the region emerges as a key hub for diagnostic innovations. Rising awareness about early detection of inflammatory and autoimmune diseases, coupled with increasing healthcare expenditure and expansion of modern diagnostic laboratories, is driving the adoption of automated ESR analyzers.

Countries like China, India, and Japan are seeing growing demand due to large patient populations and rising prevalence of chronic inflammatory conditions. Additionally, government initiatives to improve healthcare infrastructure, combined with increased accessibility to advanced laboratory technologies in tier-2 and tier-3 cities, are fueling market penetration.

The region’s focus on rapid, accurate, and cost-effective diagnostics positions Asia Pacific as a high-potential and fast-growing market for automated ESR analyzers.

global-automated-esr-analyzer-market-outlook-by-region-2025-2032

Competitive Landscape

Key competitors in the market for automated ESR analyzers are concentrating on developing new products that can be personalized for various purposes. Product manufacturers are using cutting-edge marketing techniques to increase their market share.

Increased investments in cutting-edge technologies to meet changing research needs; increased emphasis on technological innovation and advancement. Companies are heavily investing in R&D in order to increase their product portfolios and market presence globally, particularly to meet the changing needs of researchers.

Key Industry Developments:

In June 2024, HORIBA expanded its compact hematology instrument range by launching new models equipped with erythrocyte sedimentation rate (ESR) testing. The new Yumizen H550E (autoloader), H500E CT (closed tube), and Yumizen H500E OT (open tube) offered combined testing for CBC/DIFF along with ESR results from whole blood in 60 seconds, providing a comprehensive profile for inflammatory disease assessment in addition to the instruments’ already extensive functionality.

Companies Covered in Automated-ESR Analyzer Market

Streck, Inc
Alifax Holding S.p.A.
RR Mechatronics
Greiner Group (Greiner Bio One International GmbH)
ALCOR Scientific Inc.
Diesse Diagnostica Senese Spa
ELITechGroup
HORIBA
Beijing Succeeder Technology Inc.
SFRI Medical Diagnostics
Biolab Scientific
Other

Frequently Asked Questions

The global market is projected to be valued at US$407.8 Mn in 2025.

Increasing cases of rheumatoid arthritis, lupus, and chronic infections are boosting demand for routine ESR testing.

The global market is poised to witness a CAGR of 5.0% between 2025 and 2032.

Combining ESR with CBC/DIFF, CRP, or other inflammatory markers offers comprehensive diagnostic solutions, attracting hospitals and laboratories.

Streck, Inc., Alifax Holding S.p.A., RR Mechatronics, HORIBA, and others

Report Attribute	Details
Historical Data/Actuals	2019 - 2024
Forecast Period	2025 - 2032
Market Analysis	Value: US$ Mn, Volume if Applicable
Geographical Coverage	North America Europe East Asia South Asia and Oceania Middle East and Africa Latin America
Segmental Coverage	By Product By Modality By Analysis Time By End-user By Region
Competitive Analysis	Streck, Inc Alifax Holding S.p.A. RR Mechatronics Greiner Group (Greiner Bio One International GmbH) ALCOR Scientific Inc. Diesse Diagnostica Senese Spa ELITechGroup HORIBA Beijing Succeeder Technology Inc. SFRI Medical Diagnostics Biolab Scientific Other
Report Highlights	Market Forecast and Trends Competitive Intelligence & Share Analysis Growth Factors and Challenges Strategic Growth Initiatives Future Opportunities and Revenue Pockets Market Analysis Tools

Top-Down Market Sizing	Bottom-Up Market Sizing
Universe Definition: Total global/regional market identification	Unit Economics: Average transaction values, purchase frequencies, customer lifecycle
Segmentation Filters: Geographic, demographic, and behavioral constraints	Customer Segmentation: Detailed buyer persona development and sizing
Market Share Analysis: Competitive landscape assessment and share allocation	Penetration Analysis: Market penetration rates by segment and geography
Growth Rate Application: Historical trends and forward-looking growth assumptions	Scaling Methodology: Extrapolation techniques with confidence intervals

Interested in this report?

Request customization, ask for expert consulting, access a sample report, or simply express your interest—our team will assist you with the right insights and solutions.

Request Custom VersionRequest Custom Version

Clients

Media Citation

Get In Touch

Loading Report...

Medical Devices
Automated-ESR Analyzer Market